 - Cohort A: allogeneic hematopoietic cell transplantation HCT recipients who were at risk of progression to disseminated AdV disease, defined as documented evidence of 1 asymptomatic AdV viremia 1,000 copiesmL, increasing, OR 2 localized AdV infection 